Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares

18th Nov 2025 07:00

RNS Number : 8809H
CVS Group plc
18 November 2025
 

18 November 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 17 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

17/11/2025

Aggregate number of Ordinary Shares purchased:

26,379

Lowest price paid per share (GBp):

1,130.00

Highest price paid per share (GBp):

1,144.00

Volume weighted average price paid per share (GBp):

1,136.95

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,290,112 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 71,290,112 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 450,671 Ordinary Shares in aggregate at a weighted average price of 1,238.57 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

184

1140

17/11/2025 08:09:38

1334764783014121

XLON

430

1142

17/11/2025 09:05:20

1334764783020455

XLON

24

1140

17/11/2025 09:19:44

1334764783021518

XLON

49

1140

17/11/2025 09:19:44

1334764783021519

XLON

72

1140

17/11/2025 09:19:44

1334764783021520

XLON

69

1140

17/11/2025 09:19:44

1334764783021521

XLON

16

1140

17/11/2025 09:19:44

1334764783021522

XLON

698

1144

17/11/2025 10:14:06

1334764783025918

XLON

149

1144

17/11/2025 10:14:06

1334764783025919

XLON

76

1142

17/11/2025 10:26:43

1334764783026875

XLON

84

1142

17/11/2025 10:31:37

1334764783027404

XLON

489

1144

17/11/2025 10:40:23

1334764783028517

XLON

244

1144

17/11/2025 10:40:23

1334764783028518

XLON

817

1144

17/11/2025 10:48:52

1334764783029342

XLON

165

1144

17/11/2025 10:48:52

1334764783029343

XLON

432

1142

17/11/2025 10:51:30

1334764783029559

XLON

592

1142

17/11/2025 11:39:29

1334764783033730

XLON

89

1142

17/11/2025 11:39:29

1334764783033732

XLON

284

1142

17/11/2025 12:26:19

1334764783036985

XLON

16

1142

17/11/2025 12:26:19

1334764783036986

XLON

113

1142

17/11/2025 12:26:19

1334764783036989

XLON

561

1138

17/11/2025 12:40:36

1334764783037836

XLON

507

1138

17/11/2025 12:40:36

1334764783037837

XLON

76

1136

17/11/2025 13:10:10

1334764783040804

XLON

116

1136

17/11/2025 13:14:41

1334764783041124

XLON

991

1136

17/11/2025 13:14:41

1334764783041125

XLON

190

1138

17/11/2025 13:35:41

1334764783042857

XLON

937

1138

17/11/2025 13:51:08

1334764783044144

XLON

190

1138

17/11/2025 13:51:08

1334764783044147

XLON

190

1138

17/11/2025 13:51:08

1334764783044150

XLON

1609

1138

17/11/2025 13:51:08

1334764783044151

XLON

190

1138

17/11/2025 13:51:08

1334764783044152

XLON

190

1138

17/11/2025 13:51:08

1334764783044153

XLON

190

1138

17/11/2025 13:51:08

1334764783044154

XLON

190

1138

17/11/2025 13:51:08

1334764783044155

XLON

190

1138

17/11/2025 13:51:08

1334764783044156

XLON

190

1138

17/11/2025 13:51:08

1334764783044157

XLON

190

1138

17/11/2025 13:51:08

1334764783044158

XLON

190

1138

17/11/2025 13:51:08

1334764783044159

XLON

190

1138

17/11/2025 13:51:08

1334764783044160

XLON

617

1138

17/11/2025 13:51:08

1334764783044161

XLON

190

1138

17/11/2025 13:51:08

1334764783044162

XLON

110

1138

17/11/2025 13:51:08

1334764783044163

XLON

194

1138

17/11/2025 13:51:08

1334764783044164

XLON

190

1138

17/11/2025 13:51:09

1334764783044174

XLON

289

1138

17/11/2025 13:51:09

1334764783044177

XLON

5

1138

17/11/2025 13:51:09

1334764783044178

XLON

185

1138

17/11/2025 13:51:10

1334764783044179

XLON

29

1138

17/11/2025 13:51:10

1334764783044180

XLON

18

1138

17/11/2025 13:51:11

1334764783044182

XLON

43

1138

17/11/2025 13:51:11

1334764783044183

XLON

22

1138

17/11/2025 13:51:11

1334764783044184

XLON

18

1138

17/11/2025 13:51:11

1334764783044185

XLON

89

1138

17/11/2025 13:51:14

1334764783044186

XLON

42

1138

17/11/2025 13:51:14

1334764783044187

XLON

26

1138

17/11/2025 13:51:14

1334764783044189

XLON

164

1138

17/11/2025 13:51:16

1334764783044198

XLON

18

1138

17/11/2025 13:51:17

1334764783044200

XLON

172

1138

17/11/2025 13:51:19

1334764783044201

XLON

1994

1138

17/11/2025 13:51:19

1334764783044203

XLON

76

1136

17/11/2025 13:51:19

1334764783044208

XLON

990

1134

17/11/2025 14:10:36

1334764783046019

XLON

374

1134

17/11/2025 14:10:36

1334764783046020

XLON

547

1132

17/11/2025 14:13:15

1334764783046452

XLON

835

1132

17/11/2025 14:13:15

1334764783046453

XLON

1402

1130

17/11/2025 14:15:27

1334764783046723

XLON

17

1130

17/11/2025 14:15:27

1334764783046726

XLON

867

1130

17/11/2025 14:15:27

1334764783046727

XLON

17

1130

17/11/2025 14:15:27

1334764783046725

XLON

500

1130

17/11/2025 14:15:27

1334764783046724

XLON

76

1132

17/11/2025 14:31:46

1334764783048637

XLON

219

1132

17/11/2025 14:32:00

1334764783048711

XLON

243

1132

17/11/2025 14:32:00

1334764783048712

XLON

76

1136

17/11/2025 14:42:37

1334764783051049

XLON

1412

1136

17/11/2025 14:48:43

1334764783052311

XLON

1165

1136

17/11/2025 14:48:43

1334764783052313

XLON

257

1132

17/11/2025 14:52:36

1334764783053251

XLON

85

1132

17/11/2025 14:52:36

1334764783053252

XLON

266

1130

17/11/2025 15:15:55

1334764783057961

XLON

295

1136

17/11/2025 15:17:21

1334764783058239

XLON

76

1134

17/11/2025 15:17:30

1334764783058266

XLON

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) [email protected]

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGWWGUPAGRM

Related Shares:

CVS Group
FTSE 100 Latest
Value9,515.06
Change-37.24